JP2022513566A5 - - Google Patents
Info
- Publication number
- JP2022513566A5 JP2022513566A5 JP2021517866A JP2021517866A JP2022513566A5 JP 2022513566 A5 JP2022513566 A5 JP 2022513566A5 JP 2021517866 A JP2021517866 A JP 2021517866A JP 2021517866 A JP2021517866 A JP 2021517866A JP 2022513566 A5 JP2022513566 A5 JP 2022513566A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- liquid pharmaceutical
- use according
- weight
- rpl554
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024091837A JP7836853B2 (ja) | 2018-10-09 | 2024-06-05 | Hfa-134a中のrpl554を含む吸入による投与用医薬組成物 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1816447.5 | 2018-10-09 | ||
| GB1816447.5A GB2578093B (en) | 2018-10-09 | 2018-10-09 | Liquid pharmaceutical composition comprising RPL554 and HFA-134A |
| PCT/GB2019/052863 WO2020074894A1 (en) | 2018-10-09 | 2019-10-09 | Pharmaceutical compositions comprising rpl554 in hfa-134a for administration by inhalation |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024091837A Division JP7836853B2 (ja) | 2018-10-09 | 2024-06-05 | Hfa-134a中のrpl554を含む吸入による投与用医薬組成物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022513566A JP2022513566A (ja) | 2022-02-09 |
| JP2022513566A5 true JP2022513566A5 (cg-RX-API-DMAC7.html) | 2022-10-11 |
| JP7578587B2 JP7578587B2 (ja) | 2024-11-06 |
Family
ID=64394831
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021517866A Active JP7578587B2 (ja) | 2018-10-09 | 2019-10-09 | Hfa-134a中のrpl554を含む吸入による投与用医薬組成物 |
| JP2024091837A Active JP7836853B2 (ja) | 2018-10-09 | 2024-06-05 | Hfa-134a中のrpl554を含む吸入による投与用医薬組成物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024091837A Active JP7836853B2 (ja) | 2018-10-09 | 2024-06-05 | Hfa-134a中のrpl554を含む吸入による投与用医薬組成物 |
Country Status (27)
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2773142T3 (es) | 2014-05-12 | 2020-07-09 | Verona Pharma Plc | Nuevo tratamiento |
| GB201502260D0 (en) | 2015-02-11 | 2015-04-01 | Verona Pharma Plc | Salt of Pyrimido[6,1-A]Isoquinolin-4-one compound |
| GB201916915D0 (en) | 2019-11-20 | 2020-01-01 | Amr Centre Ltd | Compounds |
| GB2594480A (en) * | 2020-04-28 | 2021-11-03 | Verona Pharma Plc | New treatment |
| GB202202297D0 (en) | 2022-02-21 | 2022-04-06 | Verona Pharma Plc | Formulation production process |
| EP4609864A4 (en) * | 2022-10-28 | 2026-02-18 | Jiangsu Hengrui Pharmaceuticals Co Ltd | PHARMACEUTICAL COMPOSITION CONTAINING AN ISOQUINOLINONE COMPOUND AND RELATED PREPARATION PROCESS |
| EP4378942A1 (en) | 2022-12-02 | 2024-06-05 | Sandoz AG | Crystal form of a pde3/4 inhibitor |
| CN121620356A (zh) | 2023-06-26 | 2026-03-06 | 维罗纳制药公司 | 包含恩塞芬汀的颗粒组合物 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK1165558T3 (da) | 1999-03-31 | 2004-02-09 | Vernalis Ltd | Pyrimido[6,1-a]isoquinolin-4-on-derivater |
| SI2603509T1 (sl) * | 2010-08-09 | 2014-10-30 | Verona Pharma Plc | Kristalinična oblika spojine PIRIMIDIO(6,1-A) IZOKINOLIN-4-ENA |
| CN107875127A (zh) * | 2012-02-28 | 2018-04-06 | 艾塞尤提卡控股公司 | 可吸入药物组合物 |
| JP6560986B2 (ja) | 2013-03-15 | 2019-08-14 | ヴェローナ ファーマ ピーエルシー | 複合製剤 |
| ES2773142T3 (es) * | 2014-05-12 | 2020-07-09 | Verona Pharma Plc | Nuevo tratamiento |
| LT3193835T (lt) * | 2014-09-15 | 2018-06-11 | Verona Pharma Plc | Skysta inhaliuojama vaisto forma, apimanti rpl554 |
| GB201502260D0 (en) * | 2015-02-11 | 2015-04-01 | Verona Pharma Plc | Salt of Pyrimido[6,1-A]Isoquinolin-4-one compound |
-
2018
- 2018-10-09 GB GB1816447.5A patent/GB2578093B/en active Active
-
2019
- 2019-10-09 CA CA3113167A patent/CA3113167A1/en active Pending
- 2019-10-09 EP EP21198029.7A patent/EP3960157A1/en active Pending
- 2019-10-09 MX MX2021003599A patent/MX2021003599A/es unknown
- 2019-10-09 KR KR1020217010706A patent/KR102960903B1/ko active Active
- 2019-10-09 CN CN201980065895.8A patent/CN112912064B/zh active Active
- 2019-10-09 JP JP2021517866A patent/JP7578587B2/ja active Active
- 2019-10-09 EP EP19790718.1A patent/EP3820446B1/en active Active
- 2019-10-09 PL PL19790718T patent/PL3820446T3/pl unknown
- 2019-10-09 DK DK19790718.1T patent/DK3820446T3/da active
- 2019-10-09 US US17/280,452 patent/US20210379053A1/en not_active Abandoned
- 2019-10-09 SI SI201930145T patent/SI3820446T1/sl unknown
- 2019-10-09 AU AU2019358585A patent/AU2019358585B2/en active Active
- 2019-10-09 WO PCT/GB2019/052863 patent/WO2020074894A1/en not_active Ceased
- 2019-10-09 RS RS20211599A patent/RS62775B1/sr unknown
- 2019-10-09 PT PT197907181T patent/PT3820446T/pt unknown
- 2019-10-09 HR HRP20220053TT patent/HRP20220053T1/hr unknown
- 2019-10-09 SG SG11202102567UA patent/SG11202102567UA/en unknown
- 2019-10-09 MY MYPI2021001479A patent/MY207302A/en unknown
- 2019-10-09 IL IL282032A patent/IL282032B2/en unknown
- 2019-10-09 BR BR112021006712-4A patent/BR112021006712A2/pt unknown
- 2019-10-09 ES ES19790718T patent/ES2899744T3/es active Active
- 2019-10-09 HU HUE19790718A patent/HUE057780T2/hu unknown
- 2019-10-09 SM SM20220044T patent/SMT202200044T1/it unknown
- 2019-10-09 LT LTEPPCT/GB2019/052863T patent/LT3820446T/lt unknown
-
2021
- 2021-03-25 ZA ZA2021/02039A patent/ZA202102039B/en unknown
- 2021-03-26 MX MX2024001499A patent/MX2024001499A/es unknown
- 2021-04-06 PH PH12021550767A patent/PH12021550767A1/en unknown
-
2022
- 2022-02-02 CY CY20221100086T patent/CY1124943T1/el unknown
-
2024
- 2024-03-26 US US18/616,878 patent/US20250049781A1/en active Pending
- 2024-06-05 JP JP2024091837A patent/JP7836853B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022550664A5 (cg-RX-API-DMAC7.html) | ||
| HRP20211035T1 (hr) | Tekuća formulacija za inhalaciju koja sadrži rpl554 | |
| JP2017528479A5 (cg-RX-API-DMAC7.html) | ||
| CN102946868B (zh) | 包含抗毒蕈碱药的干粉制剂 | |
| JP2024113096A5 (cg-RX-API-DMAC7.html) | ||
| JP2018199684A (ja) | R(+)ブデソニド及び1以上の気管支拡張剤を含む医薬組成物 | |
| JP2002537249A (ja) | 喘息のためのホルモテロールおよびプロピオン酸フルチカゾンの組み合わせ | |
| SK3892000A3 (en) | Use of budesonide and formoterol for producing a composition for the treatment of chronic obstructive pulmonary disease | |
| JP2018505192A5 (cg-RX-API-DMAC7.html) | ||
| Pomázi et al. | Effect of polymers for aerolization properties of mannitol-based microcomposites containing meloxicam | |
| JP2021522161A5 (cg-RX-API-DMAC7.html) | ||
| US20100040691A1 (en) | Pharmaceutical compositions comprising methotrexate | |
| KR101668203B1 (ko) | 천식의 병세악화를 예방 및/또는 치료하기 위한 포르모테롤 및 베클로메타손 디프로피오네이트를 포함하는 조성의 용도 | |
| JP2023516630A5 (cg-RX-API-DMAC7.html) | ||
| HUP0303755A2 (hu) | Szalmeterol és flutikaszon-propionát kombináció alkalmazása és ezt tartalmazó gyógyszerkészítmény | |
| JP2022526367A5 (cg-RX-API-DMAC7.html) | ||
| KR102637303B1 (ko) | 항콜린제, 코르티코스테로이드 및 베타-아드레날린성 약물을 포함하는 건조 분말 제제의 제조 방법 | |
| JP2008502699A5 (cg-RX-API-DMAC7.html) | ||
| HRP20241621T1 (hr) | (1r,3s)-3-((5-cijano-4-feniltiazol-2-il)karbamoil)ciklopentan-1-karboksilna kiselina, namijenjena upotrebi u liječenju bolesti dišnih puteva | |
| RU2021109697A (ru) | Фармацевтические композиции, содержащие RPL554 в HFA-134A для введения посредством ингаляции | |
| KR102637298B1 (ko) | 항콜린제, 코르티코스테로이드 및 베타-아드레날린성 약물을 포함하는 건조 분말 제제의 제조 방법 | |
| TH2101002047A (th) | องค์ประกอบเชิงเภสัชกรรมซึ่งประกอบรวมด้วย rpl554 ใน hfa-134a สำหรับการดำเนินการให้โดยการสูดดม | |
| RU2022103508A (ru) | Фармацевтическая композиция, содержащая энсифентрин | |
| JP2022552489A (ja) | 肺疾患のための吸入可能な乾燥粉末組成物 | |
| NZ767296B2 (en) | Liquid Inhalation Formulation Comprising RPL554 |